| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | HERON THERAPEUTICS INC COM | 95,000 | 1,425,000 | 0.70% | ||
| 52 | PACIRA PHARMACEUTICALS INC | 31,000 | 1,414,000 | 0.69% | ||
| 53 | ROYAL GOLD INC | 19,000 | 1,331,000 | 0.65% | ||
| 54 | ALKERMES PLC | 22,000 | 1,287,000 | 0.63% | ||
| 55 | TESARO INCORPORATED | 6,700 | 1,030,000 | 0.50% | Call | |
| 56 | BLUEPRINT MEDICINES CORP COM | 24,000 | 960,000 | 0.47% | ||
| 57 | TRIPADVISOR INC | 20,000 | 863,000 | 0.42% | Call | |
| 58 | ZOGENIX INC | 67,000 | 727,000 | 0.36% | ||
| 59 | SAGE THERAPEUTICS INC | 9,000 | 639,000 | 0.31% | ||
| 60 | IMPAX LABORATORIES INC | 39,500 | 499,000 | 0.24% | ||
| 61 | BIOMARIN PHARMACEUTICAL INC | 5,100 | 447,000 | 0.22% | Call | |
| 62 | Axovant Sciences LTD | 22,000 | 329,000 | 0.16% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-17-001210, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
